Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Metatranscriptomic analysis of the microbiota of tumor tissue in colon cancer

  • Buetas, Elena
  • Conde-Pérez, Kelly
  • Concha López, Ángel
  • Celeiro, Catuxa
  • Noguera, José
  • Bou, Germán
  • Pardiñas López, Simón
  • Vallejo, J. A.
  • Poza, Margarita
  • Carda-Diéguez, Miguel
  • Mira, Alex
[Abstract] Background: Colorectal cancer (CRC) is the second leading cause of cancer-related deaths, accounting for more than 900,000 deaths a year worldwide. Microbial dysbiosis, including the presence of oral bacteria in the gut, has been linked to CRC. Some mechanisms by which specific microorganisms potentially drive tumorigenesis have been described, but there is a lack of studies elucidating whole microbiota activity in the tumor and their implication for the development of the disease. Here, the metatranscriptomic data of tumor and control tissue-associated microbiota (n = 18 pairs), as well as from subgingival sulcus (n = 15) of CRC patients, was analyzed. Results: We confirmed that Fusobacterium nucleatum was more active in the tumor tissue than in the control gut mucosa. In addition, the activity of this species was positively correlated with other oral bacteria in the tumors, including Parvimonas micra, Peptostreptococcus stomatis, and Granulicatella adiacens, along with gut bacteria like Hungatella hathewayi, suggesting a potential relationship among them. Regarding bacterial gene expression, a change in the functional profile was observed, including a higher expression of genes associated with carbon metabolism in control in contrast to an increase of amino acid-related genes in tumor. Furthermore, genes implicated in the biosynthesis and transport of lipopolysaccharide were increased in tumors. Interestingly, a significantly higher expression in tumor than control tissue of potential virulence factors from F. nucleatum was found, supporting their relevance in niche colonization and tumorigenesis. Correlation analysis of the bacterial activity with the host transcriptional profile showed significant correlations of the Fusobacterium-Peptostreptotoccus-Hungatella cluster with human genes involved in inflammation and metastasis, confirming the association of this microbial consortium with tumor development. For the first time, the gene expression profiles of oral bacteria in the gut and the oral cavity were compared. The cluster of co-active bacteria identified in tumors was partially found in the oral samples, suggesting a stable interaction and potential synergy. Although there were thousands of differentially expressed genes between subgingival sulcus and tumor tissue, the expression of key virulence factors was not significantly different. Conclusions: In short, this study discovered new traits about tumor microbial-associated composition and activity and its connection with the oral composition that would be essential to unravel the translocation, colonization, and tumorigenesis of the CRC. Video Abstract., This work has been supported by the project RTI2018‐102032‐B‐I00 from the Spanish Ministry of Science and Innovation to AM. EB was supported by a grant from the Spanish Ministry of Science and Innovation PRE2019‐088126. In addition, the present study received funding from the Instituto de Salud Carlos III (ISCIII), Spain, through the projects PI20/00413 and PI23/00696, co-financed by the European Union (EU) to MP. KC was financially supported by the Spanish Association against Cancer (AECC).
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Microbiome Differential Abundance Methodologies to Detect Relevant Taxa Associated with Chemotherapy Toxicity Rate in Colorectal Cancer

  • Martin-De Arribas, E.
  • Conde-Pérez, Kelly
  • Aja-Macaya, Pablo
  • Vallejo, J. A.
  • Bou, Germán
  • López-Cheda, Ana
  • Jácome, M. A.
  • Ladra, Susana
  • Poza, Margarita
Financiado para publicación en acceso aberto: Universidade da Coruña/CISUG The data supporting this study are publicly available in the National Centre for Biotechnology Information (NCBI) Sequence Read Archive (SRA) database under the accession codes PRJNA911189 and PRJNA893853. The complete metadata set used in this paper is available in our GitHub repository (see Section 2.6). The external validation dataset used in this study will be available in the GitHub repository for this paper (see Section 2.6). At the same time, it can be downloaded directly from the original paper (Hillege et al. 2025). Supplementary material is available at Bioinformatics Advances online., [Abstract]: Motivation. The interplay between microbial communities and treatment outcomes represents a promising area in pharmacomicrobiomics. Identifying microbial biomarkers that differentiate toxicity levels could inform personalized cancer strategies. However, biomarker identification is strongly influenced by methodological choices in differential abundance analysis (DAA), and most studies focus on individual outcomes despite toxicity being inherently multifactorial. In this study, we defined a multi-dimensional toxicity variable integrating clinical symptoms and treatment modifications to stratify colorectal cancer patients. We then evaluated six widely used DAA methods (ALDEx2, ANCOM-BC, DESeq2, LEfSe, LinDA, and ZicoSeq) to assess how analytical variability affects the detection of microbiome signatures associated with chemotherapy-related toxicity. Analyses were performed under different preprocessing and multiple-testing correction strategies, and consistency was further examined using an independent validation dataset. Results. Substantial variability was observed across methods, with limited overlap in detected taxa but moderate concordance in effect-size rankings. ANCOM-BC showed the most consistent overall performance across analytical scenarios, although trade-offs remained between taxa detection, ranking, and direction of association. Despite this variability, a subset of taxa was consistently identified across methods, including Parvimonas, Eubacterium ventriosum group, and Ruminococcus in the low-toxicity group, and members of the Lachnospiraceae family, such as Fusicatenibacter, Lachnospira, and the Lachnospiraceae NK4A136 group, in the severe-toxicity group. Analyses in the external validation dataset supported the reproducibility of methodological patterns, despite differences in cohort composition and sequencing strategy. These findings highlight the methodological dependence of microbiome biomarker discovery and the potential of pre-treatment microbial signatures to stratify toxicity risk. View collectively, our results support a context-dependent approach to DAA method selection in clinical microbiome studies., This work was supported by the Spanish Ministry of Science and Innovation with funds from the European Union NextGenerationEU; GAIN and MRR funds, Recovery, Transformation and Resilience Plan (PRTRC17.I1) and from the Autonomous Community of Galicia within the framework of the Biotechnology Plan Applied to Health (DATAMICROCCR); GAIN/Xunta de Galicia (GRC: ED431C 2025/34, ED431C-2024/14); grant PID2023-147127OB-I00, funded by MCIN/ AEI/10.13039/501100011033/; and the Xunta de Galicia through the collaboration agreement between the Department of Culture, Education, Vocational Training and Universities and the Galician universities for the reinforcement of the research centres of the Galician University System, CIGUS (CITIC). This study also received funding from the Instituto de Salud Carlos III (ISCIII), Spain, through the projects PI20/00413 and PI23/00696, co-funded by the European Union [to M.P.]. Finally, project IN607A 2024/09, awarded to G.B., also funded this research. Funding for open access charge: Universidade da Coruña/CISUG., Xunta de Galicia; ED431C 2025/34, Xunta de Galicia; ED431C-2024/14, Xunta de Galicia; IN607A 2024/09, https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/bioinformaticsadvances/6/1/10.1093_bioadv_vbag148/1/vbag148_supplementary_data.pdf?Expires=1786057871&Signature=3JyWGTBNJMk04Mo5YA478REuErHCckTX6BI6fB6LVUetTCLbgdQT2flCwWz3IJduY3I0wJGqrcGVq1LgHo5M3e8jAQggncSqnXBgVbCB~TCudFbcDFAKw3i8rF34P56E58L4krtm0F8cRDuW3WwGPZUvqxlETfuGcCUBU9XkLTLyOojjwVw78QXwxPN80aqHX9qNlKvwfcsVdRh52UpoK1rCRUHFQQrSGevPmMBL0M4tiCKg~CX7kUolD8o3BZvyKe4QzGXro7pEZYfRybU53ke-R3t0b05bo-oIK0xqkCwDqMhZZgriJYrleG1hpgW8EZ1Iyy3iwi7g4O86QmwrZQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA
RUC. Repositorio da Universidade da Coruña
Publication Contribución de congreso (ConferenceOutput)

Machine Learning Decodes the Microbiome: Advancing Diagnostic Accuracy in Gastrointestinal Diseases

  • Wasim, Ayesha
  • Martin-De Arribas, E.
  • Ladra, Susana
  • Poza, Margarita
  • Fernández-Lozano, Carlos
Presentado en: 11th ISM World Congress on Targeting Microbiota, 14-15 October 2024, Malta Versión aceptada, [Abstract]: This study evaluates the diagnostic accuracy of machine learning (ML) models on gut microbiome data for gastrointestinal diseases. By assessing batch correction and profiling strategies, the results show that species-level taxonomic features excel for Crohn's disease, whereas ComBat-seq batch correction improves predictive accuracy in colorectal cancer. Algorithms like Random Forest and XGBoost proved most effective, offering guidance for reproducible non-invasive diagnostics., Spanish Ministry of Science and Innovation with funds from the European Union NextGenerationEU, Horizon 2020 research and innovation programme under a Marie Skłodowska-Curie agreement 101034261 (H2020-MSCA-COFUND), from GAIN and MRR funds, Recovery, Transformation and Resilience Plan (PRTRC17.I1), NextGenerationEU (DATAMICROCCR); MCIN/AEI/10.13039/501100011033, GAIN/Xunta de Galicia (GRC: ED431C 2021/53). The present study received funding from the Instituto de Salud Carlos III (ISCIII), Spain, through the projects PI20/00413 and PI23/00696, cofounded by the European Union (EU) to MP., Xunta de Galicia; ED431C 2021/53
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Anti-inflammatory and Antimicrobial Efficacy of Coconut Oil for Periodontal Pathogens: A Triple-Blind Randomized Clinical Trial

  • Pardiñas López, Simón
  • García-Caro, Mónica E.
  • Vallejo, J. A.
  • Aja-Macaya, Pablo
  • Conde-Pérez, Kelly
  • Nión, P.
  • Khouly, Ismael
  • Bou, Germán
  • Rodríguez-Cendal, Ana Isabel
  • Díaz-Prado, Silvia
  • Poza, Margarita
Randomized controlled trial, Financiado para publicación en acceso aberto: Universidade da Coruña/CISUG, [Abstract] Objectives: To evaluate the effect of coconut oil on the oral bacteriome and inflammatory response in patients with periodontitis by integrating next-generation sequencing analyses of pathogenic bacterial shifts and quantification of inflammatory markers, thereby assessing its potential as a natural adjunct to standard nonsurgical periodontal therapy. Materials and methods: A triple-blind clinical trial was conducted with 30 participants diagnosed with periodontitis, randomized into 3 groups: (1) coconut oil, (2) chlorhexidine and (3) placebo. Saliva and gingival crevicular fluid (GCF) samples were collected before treatment, one month after treatment, and one month post-non-surgical periodontal therapy. Bacterial DNA was extracted, and the V3-V4 region of the 16 S rRNA gene was PCR-amplified and sequenced using Illumina MiSeq technologies. Inflammatory biomarkers, including Interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), were quantified from GCF samples. Results: Coconut oil treatment significantly reduced pathogenic bacterial families such as Spirochaetaceae and Tannerellaceae while promoting beneficial bacteria such as Streptococcaceae. At the genus and species levels, coconut oil reduced pathogens such as Tannerella forsythia and Treponema denticola along with increase in beneficial bacteria such as Streptococcus. The subgingival microbial dysbiosis index improved significantly in both coconut oil and chlorhexidine groups. Furthermore, the coconut oil demonstrated a reduction in IL-6 and TNF-α levels, indicating decreased local inflammation. Conclusions: Coconut oil treatment significantly modulated the oral microbiome and reduced inflammatory markers in patients with periodontitis, suggesting its potential as a natural and effective adjunct in periodontal therapy. Clinical relevance: This study highlights coconut oil's potential as a natural adjunct in periodontal therapy, effectively reducing pathogenic bacteria and inflammatory markers (IL-6, TNF-α). It offers a safe alternative to chlorhexidine, promoting microbiome balance and improved periodontal health., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. The present study received funding from the Instituto de Salud Carlos III (ISCIII), Spain, through the projects PI20/00413 and PI23/00696, co-funded by the European Union (EU), to M. P and by CIBER de Enfermedades Infecciosas CIBERINFEC, ISCIII (CB21/13/00055) to G. B and M. P. Grupos con Potencial de Crecemento from Xunta de Galicia, Galicia, Spain (ED431B 2023/58 and ED431B 2020/55) and Fundación Pública Galega de Investigación Biomédica (FINIBIC). Funding for open access charge: Universidade da Coruña/CISUG., Xunta de Galicia; ED431B 2023/58, Xunta de Galicia; ED431B 2020/55
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Nanopore full length 16S rRNA gene sequencing increases species resolution in bacterial biomarker discovery

  • Aja-Macaya, Pablo
  • Conde-Pérez, Kelly
  • Noelia Trigo-Tasende
  • Nasser-Ali, Mohammed
  • Nión, P.
  • Rumbo-Feal, Soraya
  • Ladra, Susana
  • Bou, Germán
  • Vallejo, J. A.
  • Poza, Margarita
Raw sequence reads generated from 16S rRNA gene sequencing by MiSeq (Illumina-V3V4) and MinION (ONT-V1V9, Dorado sup v4.1.0) are available in the NCBI SRA database under bioproject PRJNA911189. Used scripts and additional documentation are available at https://github.com/Pablo-Aja-Macaya/CRC-ONT16S., [Abstract]: Discovery of disease-related bacterial biomarkers could be a useful approach for early prevention or diagnosis of various afflictions, such as colorectal cancer. This typically involves analyzing small regions of the 16S rRNA gene (e.g. V3V4) through short-read technologies like Illumina, obtaining genus-level results. However, recent developments in third-generation sequencing, such as Oxford Nanopore Technologies (ONT)’s new R10.4.1 chemistry and its improved basecalling models, are beginning to allow for a more complete and accessible species-level analysis through full-length 16S rRNA gene sequencing (spanning regions V1-V9). Thus, the goal of this study was to compare and evaluate both approaches, using colorectal cancer biomarker discovery as a representative case. This was achieved through the analysis of feces from 123 subjects, comparing both methods (Illumina-V3V4 with DADA2 and QIIME2 vs. ONT-V1V9 with Emu), multiple Dorado basecalling models (fast, hac and sup) and multiple databases (SILVA vs. Emu’s Default database). Basecalling models broadly resulted in similar taxonomic output, but had significantly higher observed species and different taxonomic identification the lower the basecalling quality (p-value<0.05). Database choice with Emu influenced the identified species greatly, with Emu’s Default database obtaining significantly higher diversity and identified species than SILVA (p-value<0.05). However, it overconfidently classified at times what should be an unknown species as the closest match due to its database structure. Bacterial abundance between Illumina-V3V4 and ONT-V1V9 at the genus level correlated well (R2 0.8). Nanopore sequencing identified more specific bacterial biomarkers for colorectal cancer than those obtained with Illumina, such as Parvimonas micra, Fusobacterium nucleatum, Peptostreptococcus stomatis, Peptostreptococcus anaerobius, Gemella morbillorum, Clostridium perfringens, Bacteroides fragilis and Sutterella wadsworthensis. Prediction of colorectal cancer through manual feature selection and machine learning resulted in an AUC of 0.87 with 14 species or 0.82 with just 4 species (P. micra, F. nucleatum, B. fragilis and Agathobaculum butyriciproducens). Full 16S rRNA V1V9 sequencing through Oxford Nanopore and its new R10.4.1 chemistry achieved accurate species-level bacterial identification, facilitating the discovery of more precise disease-related biomarkers and increasing the taxonomic fidelity of future microbiome analyses., This study has been funded by the Instituto de Salud Carlos III (ISCIII), through the projects PI20/00413 and PI23/00696, cofunded by the European Union (EU) to MP. Also, the work was funded by the project IN607A2024/09 from Xunta de Galicia (Spain) to GB. Additionally, it has been supported by the project RTI2018-102032-B-I00 from the Spanish Ministry of Science and Innovation to AM and by CIBER INFEC ISCIII (CB21/13/00055) to GB and MP. KC-P was financially supported by the Spanish Association against Cancer (AECC) from December 2019 to December 2023. Additionally, this work, integrated into the framework of PERTE for Vanguard Health, has been co-financed by the Spanish Ministry of Science, Innovation and Universities with funds from the European Union NextGenerationEU, from the Recovery, Transformation and Resilience Plan (PRTR-C17.I1) and from the Autonomous Community of Galicia within the framework of the Biotechnology Plan Applied to Health to SL., Xunta de Galicia; IN607A2024/09